nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—blood vessel—stomach cancer	0.0186	0.1	CbGeAlD
Treprostinil—P2RY12—hematopoietic system—stomach cancer	0.0156	0.0839	CbGeAlD
Treprostinil—P2RY12—epithelium—stomach cancer	0.0142	0.0767	CbGeAlD
Treprostinil—PPARD—hematopoietic system—stomach cancer	0.0129	0.0697	CbGeAlD
Treprostinil—PPARD—pancreas—stomach cancer	0.0105	0.0567	CbGeAlD
Treprostinil—PTGIR—hematopoietic system—stomach cancer	0.00992	0.0535	CbGeAlD
Treprostinil—PPARD—lymphoid tissue—stomach cancer	0.0091	0.049	CbGeAlD
Treprostinil—PTGIR—epithelium—stomach cancer	0.00907	0.0489	CbGeAlD
Treprostinil—PPARD—digestive system—stomach cancer	0.00899	0.0484	CbGeAlD
Treprostinil—P2RY12—endocrine gland—stomach cancer	0.00894	0.0482	CbGeAlD
Treprostinil—PTGIR—smooth muscle tissue—stomach cancer	0.00874	0.0471	CbGeAlD
Treprostinil—PTGIR—pancreas—stomach cancer	0.00808	0.0436	CbGeAlD
Treprostinil—PPARD—endocrine gland—stomach cancer	0.00743	0.04	CbGeAlD
Treprostinil—PTGIR—digestive system—stomach cancer	0.0069	0.0372	CbGeAlD
Treprostinil—PPARD—liver—stomach cancer	0.0067	0.0361	CbGeAlD
Treprostinil—PTGIR—endocrine gland—stomach cancer	0.0057	0.0307	CbGeAlD
Treprostinil—PTGIR—liver—stomach cancer	0.00514	0.0277	CbGeAlD
Treprostinil—PPARD—lymph node—stomach cancer	0.00513	0.0277	CbGeAlD
Treprostinil—Nadolol—ADRB1—stomach cancer	0.00445	0.543	CrCbGaD
Treprostinil—PTGIR—lymph node—stomach cancer	0.00394	0.0212	CbGeAlD
Treprostinil—Nadolol—ADRB2—stomach cancer	0.00374	0.457	CrCbGaD
Treprostinil—CYP2C9—hematopoietic system—stomach cancer	0.00355	0.0191	CbGeAlD
Treprostinil—CYP2C9—digestive system—stomach cancer	0.00247	0.0133	CbGeAlD
Treprostinil—CYP2C9—endocrine gland—stomach cancer	0.00204	0.011	CbGeAlD
Treprostinil—CYP2C9—liver—stomach cancer	0.00184	0.0099	CbGeAlD
Treprostinil—Anaemia—Docetaxel—stomach cancer	0.000654	0.00151	CcSEcCtD
Treprostinil—Depression—Methotrexate—stomach cancer	0.00065	0.0015	CcSEcCtD
Treprostinil—Ill-defined disorder—Capecitabine—stomach cancer	0.000635	0.00147	CcSEcCtD
Treprostinil—Syncope—Docetaxel—stomach cancer	0.000634	0.00146	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—stomach cancer	0.000633	0.00146	CcSEcCtD
Treprostinil—Anaemia—Capecitabine—stomach cancer	0.000633	0.00146	CcSEcCtD
Treprostinil—Body temperature increased—Fluorouracil—stomach cancer	0.000632	0.00146	CcSEcCtD
Treprostinil—Palpitations—Docetaxel—stomach cancer	0.000625	0.00144	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—stomach cancer	0.000622	0.00144	CcSEcCtD
Treprostinil—Loss of consciousness—Docetaxel—stomach cancer	0.000622	0.00144	CcSEcCtD
Treprostinil—Malaise—Capecitabine—stomach cancer	0.000617	0.00143	CcSEcCtD
Treprostinil—Cough—Docetaxel—stomach cancer	0.000617	0.00142	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—stomach cancer	0.000615	0.00142	CcSEcCtD
Treprostinil—Syncope—Capecitabine—stomach cancer	0.000614	0.00142	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—stomach cancer	0.000614	0.00142	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—stomach cancer	0.000609	0.00141	CcSEcCtD
Treprostinil—Palpitations—Capecitabine—stomach cancer	0.000605	0.0014	CcSEcCtD
Treprostinil—Chest pain—Docetaxel—stomach cancer	0.000602	0.00139	CcSEcCtD
Treprostinil—Arthralgia—Docetaxel—stomach cancer	0.000602	0.00139	CcSEcCtD
Treprostinil—Myalgia—Docetaxel—stomach cancer	0.000602	0.00139	CcSEcCtD
Treprostinil—Loss of consciousness—Capecitabine—stomach cancer	0.000602	0.00139	CcSEcCtD
Treprostinil—Asthenia—Irinotecan—stomach cancer	0.000599	0.00138	CcSEcCtD
Treprostinil—Cough—Capecitabine—stomach cancer	0.000597	0.00138	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—stomach cancer	0.000593	0.00137	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—stomach cancer	0.000588	0.00136	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—stomach cancer	0.000585	0.00135	CcSEcCtD
Treprostinil—Myalgia—Capecitabine—stomach cancer	0.000583	0.00135	CcSEcCtD
Treprostinil—Chest pain—Capecitabine—stomach cancer	0.000583	0.00135	CcSEcCtD
Treprostinil—Arthralgia—Capecitabine—stomach cancer	0.000583	0.00135	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—stomach cancer	0.000582	0.00134	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—stomach cancer	0.000581	0.00134	CcSEcCtD
Treprostinil—Anxiety—Capecitabine—stomach cancer	0.000581	0.00134	CcSEcCtD
Treprostinil—Oedema—Docetaxel—stomach cancer	0.000577	0.00133	CcSEcCtD
Treprostinil—Discomfort—Capecitabine—stomach cancer	0.000576	0.00133	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—stomach cancer	0.000576	0.00133	CcSEcCtD
Treprostinil—Infection—Docetaxel—stomach cancer	0.000573	0.00132	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—stomach cancer	0.000573	0.00132	CcSEcCtD
Treprostinil—Diarrhoea—Irinotecan—stomach cancer	0.000571	0.00132	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—stomach cancer	0.000568	0.00131	CcSEcCtD
Treprostinil—Shock—Docetaxel—stomach cancer	0.000568	0.00131	CcSEcCtD
Treprostinil—Pruritus—Fluorouracil—stomach cancer	0.000566	0.00131	CcSEcCtD
Treprostinil—Thrombocytopenia—Docetaxel—stomach cancer	0.000565	0.0013	CcSEcCtD
Treprostinil—Tachycardia—Docetaxel—stomach cancer	0.000563	0.0013	CcSEcCtD
Treprostinil—Oedema—Capecitabine—stomach cancer	0.000559	0.00129	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—stomach cancer	0.000558	0.00129	CcSEcCtD
Treprostinil—Infection—Capecitabine—stomach cancer	0.000555	0.00128	CcSEcCtD
Treprostinil—Dizziness—Irinotecan—stomach cancer	0.000552	0.00127	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—stomach cancer	0.000551	0.00127	CcSEcCtD
Treprostinil—Anorexia—Docetaxel—stomach cancer	0.00055	0.00127	CcSEcCtD
Treprostinil—Shock—Capecitabine—stomach cancer	0.00055	0.00127	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—stomach cancer	0.000549	0.00127	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—stomach cancer	0.000549	0.00127	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—stomach cancer	0.000548	0.00127	CcSEcCtD
Treprostinil—Diarrhoea—Fluorouracil—stomach cancer	0.000547	0.00126	CcSEcCtD
Treprostinil—Thrombocytopenia—Capecitabine—stomach cancer	0.000547	0.00126	CcSEcCtD
Treprostinil—Tachycardia—Capecitabine—stomach cancer	0.000545	0.00126	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—stomach cancer	0.000544	0.00126	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—stomach cancer	0.00054	0.00125	CcSEcCtD
Treprostinil—Hypotension—Docetaxel—stomach cancer	0.000539	0.00125	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—stomach cancer	0.000538	0.00124	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—stomach cancer	0.000533	0.00123	CcSEcCtD
Treprostinil—Anorexia—Capecitabine—stomach cancer	0.000533	0.00123	CcSEcCtD
Treprostinil—Vomiting—Irinotecan—stomach cancer	0.000531	0.00123	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—stomach cancer	0.00053	0.00122	CcSEcCtD
Treprostinil—Dizziness—Fluorouracil—stomach cancer	0.000529	0.00122	CcSEcCtD
Treprostinil—Rash—Irinotecan—stomach cancer	0.000526	0.00122	CcSEcCtD
Treprostinil—Dermatitis—Irinotecan—stomach cancer	0.000526	0.00121	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000526	0.00121	CcSEcCtD
Treprostinil—Headache—Irinotecan—stomach cancer	0.000523	0.00121	CcSEcCtD
Treprostinil—Hypotension—Capecitabine—stomach cancer	0.000522	0.00121	CcSEcCtD
Treprostinil—Insomnia—Docetaxel—stomach cancer	0.000522	0.00121	CcSEcCtD
Treprostinil—Paraesthesia—Docetaxel—stomach cancer	0.000518	0.0012	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—stomach cancer	0.000516	0.00119	CcSEcCtD
Treprostinil—Dyspnoea—Docetaxel—stomach cancer	0.000515	0.00119	CcSEcCtD
Treprostinil—Erythema—Methotrexate—stomach cancer	0.00051	0.00118	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—stomach cancer	0.00051	0.00118	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000509	0.00118	CcSEcCtD
Treprostinil—Flushing—Epirubicin—stomach cancer	0.000509	0.00117	CcSEcCtD
Treprostinil—Vomiting—Fluorouracil—stomach cancer	0.000508	0.00117	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—stomach cancer	0.000508	0.00117	CcSEcCtD
Treprostinil—Dyspepsia—Docetaxel—stomach cancer	0.000508	0.00117	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—stomach cancer	0.000507	0.00117	CcSEcCtD
Treprostinil—Insomnia—Capecitabine—stomach cancer	0.000505	0.00117	CcSEcCtD
Treprostinil—Rash—Fluorouracil—stomach cancer	0.000504	0.00116	CcSEcCtD
Treprostinil—Dermatitis—Fluorouracil—stomach cancer	0.000504	0.00116	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—stomach cancer	0.000503	0.00116	CcSEcCtD
Treprostinil—Paraesthesia—Capecitabine—stomach cancer	0.000502	0.00116	CcSEcCtD
Treprostinil—Decreased appetite—Docetaxel—stomach cancer	0.000502	0.00116	CcSEcCtD
Treprostinil—Headache—Fluorouracil—stomach cancer	0.000501	0.00116	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—stomach cancer	0.000499	0.00115	CcSEcCtD
Treprostinil—Dyspnoea—Capecitabine—stomach cancer	0.000498	0.00115	CcSEcCtD
Treprostinil—Fatigue—Docetaxel—stomach cancer	0.000498	0.00115	CcSEcCtD
Treprostinil—Nausea—Irinotecan—stomach cancer	0.000496	0.00115	CcSEcCtD
Treprostinil—Pain—Docetaxel—stomach cancer	0.000494	0.00114	CcSEcCtD
Treprostinil—Back pain—Methotrexate—stomach cancer	0.000493	0.00114	CcSEcCtD
Treprostinil—Dyspepsia—Capecitabine—stomach cancer	0.000492	0.00114	CcSEcCtD
Treprostinil—Decreased appetite—Capecitabine—stomach cancer	0.000486	0.00112	CcSEcCtD
Treprostinil—Fatigue—Capecitabine—stomach cancer	0.000482	0.00111	CcSEcCtD
Treprostinil—Pain—Capecitabine—stomach cancer	0.000478	0.0011	CcSEcCtD
Treprostinil—Erythema—Epirubicin—stomach cancer	0.000477	0.0011	CcSEcCtD
Treprostinil—Feeling abnormal—Docetaxel—stomach cancer	0.000476	0.0011	CcSEcCtD
Treprostinil—Nausea—Fluorouracil—stomach cancer	0.000475	0.0011	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—stomach cancer	0.000473	0.00109	CcSEcCtD
Treprostinil—Gastrointestinal pain—Docetaxel—stomach cancer	0.000472	0.00109	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—stomach cancer	0.000471	0.00109	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—stomach cancer	0.000471	0.00109	CcSEcCtD
Treprostinil—Tension—Epirubicin—stomach cancer	0.000468	0.00108	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—stomach cancer	0.000463	0.00107	CcSEcCtD
Treprostinil—Back pain—Epirubicin—stomach cancer	0.000461	0.00107	CcSEcCtD
Treprostinil—Feeling abnormal—Capecitabine—stomach cancer	0.00046	0.00106	CcSEcCtD
Treprostinil—Malaise—Methotrexate—stomach cancer	0.00046	0.00106	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—stomach cancer	0.000459	0.00106	CcSEcCtD
Treprostinil—Gastrointestinal pain—Capecitabine—stomach cancer	0.000457	0.00106	CcSEcCtD
Treprostinil—Abdominal pain—Docetaxel—stomach cancer	0.000456	0.00105	CcSEcCtD
Treprostinil—Body temperature increased—Docetaxel—stomach cancer	0.000456	0.00105	CcSEcCtD
Treprostinil—Cough—Methotrexate—stomach cancer	0.000445	0.00103	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—stomach cancer	0.000443	0.00102	CcSEcCtD
Treprostinil—Body temperature increased—Capecitabine—stomach cancer	0.000442	0.00102	CcSEcCtD
Treprostinil—Abdominal pain—Capecitabine—stomach cancer	0.000442	0.00102	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—stomach cancer	0.000441	0.00102	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—stomach cancer	0.000441	0.00102	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—stomach cancer	0.000434	0.001	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—stomach cancer	0.000434	0.001	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—stomach cancer	0.000434	0.001	CcSEcCtD
Treprostinil—Tension—Doxorubicin—stomach cancer	0.000433	0.001	CcSEcCtD
Treprostinil—Malaise—Epirubicin—stomach cancer	0.00043	0.000993	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—stomach cancer	0.000429	0.00099	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—stomach cancer	0.000429	0.00099	CcSEcCtD
Treprostinil—Syncope—Epirubicin—stomach cancer	0.000428	0.000988	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—stomach cancer	0.000427	0.000986	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—stomach cancer	0.000424	0.00098	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—stomach cancer	0.000422	0.000973	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—stomach cancer	0.000419	0.000968	CcSEcCtD
Treprostinil—Cough—Epirubicin—stomach cancer	0.000416	0.000961	CcSEcCtD
Treprostinil—Asthenia—Docetaxel—stomach cancer	0.000414	0.000956	CcSEcCtD
Treprostinil—Infection—Methotrexate—stomach cancer	0.000413	0.000954	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—stomach cancer	0.000409	0.000946	CcSEcCtD
Treprostinil—Pruritus—Docetaxel—stomach cancer	0.000408	0.000943	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—stomach cancer	0.000408	0.000942	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—stomach cancer	0.000407	0.00094	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—stomach cancer	0.000406	0.000938	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—stomach cancer	0.000406	0.000938	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—stomach cancer	0.000406	0.000938	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—stomach cancer	0.000405	0.000934	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—stomach cancer	0.000401	0.000926	CcSEcCtD
Treprostinil—Asthenia—Capecitabine—stomach cancer	0.000401	0.000926	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—stomach cancer	0.000398	0.000919	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—stomach cancer	0.000397	0.000916	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—stomach cancer	0.000396	0.000914	CcSEcCtD
Treprostinil—Pruritus—Capecitabine—stomach cancer	0.000395	0.000913	CcSEcCtD
Treprostinil—Diarrhoea—Docetaxel—stomach cancer	0.000395	0.000912	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—stomach cancer	0.00039	0.000901	CcSEcCtD
Treprostinil—Oedema—Epirubicin—stomach cancer	0.000389	0.000899	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—stomach cancer	0.000389	0.000898	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—stomach cancer	0.000388	0.000896	CcSEcCtD
Treprostinil—Infection—Epirubicin—stomach cancer	0.000387	0.000893	CcSEcCtD
Treprostinil—Cough—Doxorubicin—stomach cancer	0.000385	0.000889	CcSEcCtD
Treprostinil—Shock—Epirubicin—stomach cancer	0.000383	0.000884	CcSEcCtD
Treprostinil—Diarrhoea—Capecitabine—stomach cancer	0.000382	0.000883	CcSEcCtD
Treprostinil—Dizziness—Docetaxel—stomach cancer	0.000382	0.000881	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—stomach cancer	0.000381	0.00088	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—stomach cancer	0.00038	0.000877	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000379	0.000875	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—stomach cancer	0.000376	0.000869	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—stomach cancer	0.000376	0.000868	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—stomach cancer	0.000376	0.000868	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—stomach cancer	0.000376	0.000868	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—stomach cancer	0.000374	0.000865	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—stomach cancer	0.000374	0.000863	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—stomach cancer	0.000371	0.000857	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—stomach cancer	0.000371	0.000857	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—stomach cancer	0.000371	0.000856	CcSEcCtD
Treprostinil—Dizziness—Capecitabine—stomach cancer	0.00037	0.000853	CcSEcCtD
Treprostinil—Vomiting—Docetaxel—stomach cancer	0.000367	0.000847	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—stomach cancer	0.000366	0.000846	CcSEcCtD
Treprostinil—Rash—Docetaxel—stomach cancer	0.000364	0.00084	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—stomach cancer	0.000364	0.00084	CcSEcCtD
Treprostinil—Dermatitis—Docetaxel—stomach cancer	0.000364	0.00084	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—stomach cancer	0.000362	0.000835	CcSEcCtD
Treprostinil—Headache—Docetaxel—stomach cancer	0.000362	0.000835	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—stomach cancer	0.00036	0.000832	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—stomach cancer	0.000359	0.000828	CcSEcCtD
Treprostinil—Infection—Doxorubicin—stomach cancer	0.000358	0.000826	CcSEcCtD
Treprostinil—Pain—Methotrexate—stomach cancer	0.000356	0.000821	CcSEcCtD
Treprostinil—Vomiting—Capecitabine—stomach cancer	0.000355	0.00082	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000355	0.000819	CcSEcCtD
Treprostinil—Shock—Doxorubicin—stomach cancer	0.000354	0.000818	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—stomach cancer	0.000353	0.000814	CcSEcCtD
Treprostinil—Rash—Capecitabine—stomach cancer	0.000352	0.000814	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—stomach cancer	0.000352	0.000813	CcSEcCtD
Treprostinil—Dermatitis—Capecitabine—stomach cancer	0.000352	0.000813	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—stomach cancer	0.000352	0.000812	CcSEcCtD
Treprostinil—Headache—Capecitabine—stomach cancer	0.00035	0.000808	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—stomach cancer	0.00035	0.000807	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—stomach cancer	0.000347	0.000801	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—stomach cancer	0.000343	0.000793	CcSEcCtD
Treprostinil—Nausea—Docetaxel—stomach cancer	0.000343	0.000792	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—stomach cancer	0.000343	0.000792	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—stomach cancer	0.000343	0.000791	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—stomach cancer	0.00034	0.000785	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—stomach cancer	0.000338	0.000781	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—stomach cancer	0.000337	0.000777	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—stomach cancer	0.000336	0.000775	CcSEcCtD
Treprostinil—Pain—Epirubicin—stomach cancer	0.000333	0.000769	CcSEcCtD
Treprostinil—Nausea—Capecitabine—stomach cancer	0.000332	0.000766	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—stomach cancer	0.000329	0.000759	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—stomach cancer	0.000329	0.000759	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000328	0.000758	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—stomach cancer	0.000326	0.000752	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—stomach cancer	0.000323	0.000747	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—stomach cancer	0.000321	0.000742	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—stomach cancer	0.000321	0.000741	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—stomach cancer	0.000318	0.000735	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—stomach cancer	0.000317	0.000732	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—stomach cancer	0.000313	0.000723	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—stomach cancer	0.000311	0.000717	CcSEcCtD
Treprostinil—Pain—Doxorubicin—stomach cancer	0.000308	0.000711	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—stomach cancer	0.000308	0.000711	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—stomach cancer	0.000308	0.000711	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—stomach cancer	0.000298	0.000689	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—stomach cancer	0.000297	0.000685	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000295	0.00068	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—stomach cancer	0.000294	0.00068	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—stomach cancer	0.000285	0.000658	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—stomach cancer	0.000285	0.000658	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—stomach cancer	0.000285	0.000657	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—stomach cancer	0.000279	0.000645	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—stomach cancer	0.000275	0.000636	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—stomach cancer	0.000275	0.000635	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—stomach cancer	0.000266	0.000615	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—stomach cancer	0.000264	0.000611	CcSEcCtD
Treprostinil—Rash—Methotrexate—stomach cancer	0.000262	0.000606	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—stomach cancer	0.000262	0.000605	CcSEcCtD
Treprostinil—Headache—Methotrexate—stomach cancer	0.000261	0.000602	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—stomach cancer	0.000258	0.000597	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—stomach cancer	0.000257	0.000594	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—stomach cancer	0.000255	0.000588	CcSEcCtD
Treprostinil—Vomiting—Epirubicin—stomach cancer	0.000248	0.000572	CcSEcCtD
Treprostinil—Nausea—Methotrexate—stomach cancer	0.000247	0.000571	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—stomach cancer	0.000246	0.000569	CcSEcCtD
Treprostinil—Rash—Epirubicin—stomach cancer	0.000245	0.000567	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—stomach cancer	0.000245	0.000566	CcSEcCtD
Treprostinil—Headache—Epirubicin—stomach cancer	0.000244	0.000563	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—stomach cancer	0.000238	0.00055	CcSEcCtD
Treprostinil—Nausea—Epirubicin—stomach cancer	0.000231	0.000534	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—stomach cancer	0.000229	0.000529	CcSEcCtD
Treprostinil—Rash—Doxorubicin—stomach cancer	0.000227	0.000524	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—stomach cancer	0.000227	0.000524	CcSEcCtD
Treprostinil—Headache—Doxorubicin—stomach cancer	0.000226	0.000521	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—stomach cancer	0.000214	0.000494	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—HBEGF—stomach cancer	0.000193	0.000516	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE1—stomach cancer	0.000192	0.000514	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—stomach cancer	0.000192	0.000513	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTT1—stomach cancer	0.000191	0.000512	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RGS2—stomach cancer	0.00019	0.000509	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GAST—stomach cancer	0.00019	0.000509	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PPP2R1A—stomach cancer	0.000189	0.000507	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2A6—stomach cancer	0.000189	0.000507	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKAA1—stomach cancer	0.000188	0.000505	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RHOA—stomach cancer	0.000185	0.000496	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKR1C3—stomach cancer	0.000184	0.000493	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS3—stomach cancer	0.000183	0.000491	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RBP4—stomach cancer	0.000182	0.000487	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—stomach cancer	0.000182	0.000487	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGG—stomach cancer	0.00018	0.000483	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO1—stomach cancer	0.000179	0.00048	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRB2—stomach cancer	0.000178	0.000476	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINE1—stomach cancer	0.000177	0.000473	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—stomach cancer	0.000176	0.000473	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000176	0.000472	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000174	0.000467	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPP2R1A—stomach cancer	0.000174	0.000466	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKAA1—stomach cancer	0.000173	0.000465	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RHOA—stomach cancer	0.00017	0.000457	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS3—stomach cancer	0.000169	0.000452	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RBP4—stomach cancer	0.000167	0.000449	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—stomach cancer	0.000167	0.000448	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000163	0.000435	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SMAD4—stomach cancer	0.000161	0.000432	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CD44—stomach cancer	0.000159	0.000426	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR2—stomach cancer	0.000156	0.000419	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HSPB1—stomach cancer	0.000156	0.000419	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTP1—stomach cancer	0.000156	0.000418	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2R—stomach cancer	0.000155	0.000414	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BMP2—stomach cancer	0.000155	0.000414	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000154	0.000413	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	0.000154	0.000412	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKR1C3—stomach cancer	0.000152	0.000408	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR1A—stomach cancer	0.000151	0.000404	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ERCC2—stomach cancer	0.000147	0.000395	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PRKCB—stomach cancer	0.000146	0.000391	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ANXA1—stomach cancer	0.000145	0.00039	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HSPB1—stomach cancer	0.000144	0.000386	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR2—stomach cancer	0.000144	0.000386	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—stomach cancer	0.000143	0.000384	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2R—stomach cancer	0.000142	0.000381	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BMP2—stomach cancer	0.000142	0.000381	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	0.000141	0.000379	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB1—stomach cancer	0.000141	0.000377	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKR1C3—stomach cancer	0.00014	0.000375	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR1A—stomach cancer	0.000139	0.000371	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPP2R1A—stomach cancer	0.000135	0.000362	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RPS6—stomach cancer	0.000135	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PRKCB—stomach cancer	0.000134	0.00036	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACAD8—stomach cancer	0.000134	0.000359	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ANXA1—stomach cancer	0.000134	0.000359	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—stomach cancer	0.000133	0.000356	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTP1—stomach cancer	0.000133	0.000355	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKCB—stomach cancer	0.000132	0.000355	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—stomach cancer	0.000132	0.000354	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6ST—stomach cancer	0.000132	0.000353	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000131	0.000351	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—stomach cancer	0.000131	0.00035	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB1—stomach cancer	0.00013	0.000347	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK3—stomach cancer	0.000125	0.000335	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RPS6—stomach cancer	0.000124	0.000332	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HBEGF—stomach cancer	0.000124	0.000331	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TYMS—stomach cancer	0.000123	0.00033	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000123	0.00033	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCB—stomach cancer	0.000122	0.000327	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—stomach cancer	0.000122	0.000326	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—stomach cancer	0.000122	0.000326	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6ST—stomach cancer	0.000121	0.000325	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GMPR2—stomach cancer	0.000119	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK1—stomach cancer	0.000119	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6R—stomach cancer	0.000118	0.000315	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—RHOA—stomach cancer	0.000117	0.000314	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000115	0.000309	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—stomach cancer	0.000115	0.000308	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ERCC2—stomach cancer	0.000115	0.000307	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB2—stomach cancer	0.000114	0.000306	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000114	0.000305	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HBEGF—stomach cancer	0.000114	0.000305	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—stomach cancer	0.000112	0.000301	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—stomach cancer	0.000112	0.000301	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP2R1A—stomach cancer	0.000112	0.0003	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK1—stomach cancer	0.000109	0.000293	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—IDH3B—stomach cancer	0.000109	0.000293	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SUCLG1—stomach cancer	0.000109	0.000293	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6R—stomach cancer	0.000108	0.00029	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—RHOA—stomach cancer	0.000108	0.000289	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—stomach cancer	0.000108	0.000288	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RHOA—stomach cancer	0.000106	0.000285	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB2—stomach cancer	0.000105	0.000281	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SMAD4—stomach cancer	0.000104	0.000278	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—stomach cancer	0.000103	0.000277	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—stomach cancer	0.000103	0.000276	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP2R1A—stomach cancer	0.000103	0.000276	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—stomach cancer	0.000103	0.000275	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NDUFV1—stomach cancer	0.000102	0.000272	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NDUFS1—stomach cancer	0.000102	0.000272	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—stomach cancer	0.000101	0.000271	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—stomach cancer	9.98e-05	0.000267	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAV1—stomach cancer	9.93e-05	0.000266	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	9.93e-05	0.000266	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOA1—stomach cancer	9.91e-05	0.000265	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FYN—stomach cancer	9.86e-05	0.000264	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RHOA—stomach cancer	9.78e-05	0.000262	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SMAD4—stomach cancer	9.56e-05	0.000256	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—stomach cancer	9.54e-05	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—stomach cancer	9.49e-05	0.000254	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.49e-05	0.000254	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—stomach cancer	9.46e-05	0.000253	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—stomach cancer	9.33e-05	0.00025	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGFR2—stomach cancer	9.26e-05	0.000248	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—stomach cancer	9.18e-05	0.000246	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FYN—stomach cancer	9.07e-05	0.000243	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BLVRB—stomach cancer	9.05e-05	0.000243	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGLS—stomach cancer	9.05e-05	0.000243	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—stomach cancer	8.78e-05	0.000235	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—stomach cancer	8.73e-05	0.000234	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPAP2A—stomach cancer	8.64e-05	0.000231	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—stomach cancer	8.59e-05	0.00023	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGFR2—stomach cancer	8.52e-05	0.000228	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS2—stomach cancer	8.48e-05	0.000227	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	8.3e-05	0.000222	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—stomach cancer	8.22e-05	0.00022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—stomach cancer	8.2e-05	0.00022	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—stomach cancer	7.85e-05	0.00021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCB—stomach cancer	7.82e-05	0.00021	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS2—stomach cancer	7.8e-05	0.000209	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6ST—stomach cancer	7.79e-05	0.000209	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FBP1—stomach cancer	7.7e-05	0.000206	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CKB—stomach cancer	7.7e-05	0.000206	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA1—stomach cancer	7.7e-05	0.000206	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NDUFA2—stomach cancer	7.7e-05	0.000206	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—stomach cancer	7.56e-05	0.000203	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—stomach cancer	7.55e-05	0.000202	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—stomach cancer	7.51e-05	0.000201	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—stomach cancer	7.49e-05	0.000201	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLIN2—stomach cancer	7.24e-05	0.000194	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCB—stomach cancer	7.2e-05	0.000193	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6ST—stomach cancer	7.17e-05	0.000192	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—stomach cancer	7.17e-05	0.000192	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA2—stomach cancer	7.04e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6R—stomach cancer	6.95e-05	0.000186	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—stomach cancer	6.89e-05	0.000185	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—stomach cancer	6.87e-05	0.000184	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NT5E—stomach cancer	6.86e-05	0.000184	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGAM1—stomach cancer	6.86e-05	0.000184	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—stomach cancer	6.82e-05	0.000183	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—stomach cancer	6.82e-05	0.000183	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—stomach cancer	6.6e-05	0.000177	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—stomach cancer	6.58e-05	0.000176	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCE1—stomach cancer	6.54e-05	0.000175	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH7A1—stomach cancer	6.54e-05	0.000175	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—stomach cancer	6.52e-05	0.000175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—stomach cancer	6.51e-05	0.000174	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—stomach cancer	6.44e-05	0.000173	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—stomach cancer	6.4e-05	0.000172	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6R—stomach cancer	6.4e-05	0.000171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RHOA—stomach cancer	6.28e-05	0.000168	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—stomach cancer	6.28e-05	0.000168	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—stomach cancer	6.28e-05	0.000168	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UMPS—stomach cancer	6.27e-05	0.000168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—stomach cancer	6.21e-05	0.000166	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—stomach cancer	6e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—stomach cancer	5.99e-05	0.00016	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—stomach cancer	5.93e-05	0.000159	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—stomach cancer	5.92e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PDHA1—stomach cancer	5.83e-05	0.000156	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ECHS1—stomach cancer	5.83e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—stomach cancer	5.81e-05	0.000156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RHOA—stomach cancer	5.78e-05	0.000155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—stomach cancer	5.72e-05	0.000153	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—stomach cancer	5.51e-05	0.000148	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMP—stomach cancer	5.48e-05	0.000147	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FADS1—stomach cancer	5.48e-05	0.000147	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—stomach cancer	5.48e-05	0.000147	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—stomach cancer	5.45e-05	0.000146	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—stomach cancer	5.38e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—stomach cancer	5.35e-05	0.000143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—stomach cancer	5.24e-05	0.00014	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SREBF2—stomach cancer	5.14e-05	0.000138	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—stomach cancer	5.14e-05	0.000138	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—stomach cancer	5.12e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RORA—stomach cancer	5.07e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—stomach cancer	5.07e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—stomach cancer	5.04e-05	0.000135	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—stomach cancer	4.99e-05	0.000134	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—stomach cancer	4.97e-05	0.000133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—stomach cancer	4.95e-05	0.000133	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—stomach cancer	4.85e-05	0.00013	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—stomach cancer	4.82e-05	0.000129	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDOB—stomach cancer	4.76e-05	0.000127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—stomach cancer	4.73e-05	0.000127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—stomach cancer	4.72e-05	0.000126	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—stomach cancer	4.59e-05	0.000123	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—stomach cancer	4.57e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.48e-05	0.00012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—stomach cancer	4.48e-05	0.00012	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.47e-05	0.00012	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—stomach cancer	4.46e-05	0.00012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—stomach cancer	4.43e-05	0.000119	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX5—stomach cancer	4.42e-05	0.000118	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DPYD—stomach cancer	4.35e-05	0.000117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—stomach cancer	4.24e-05	0.000113	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—stomach cancer	4.23e-05	0.000113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—stomach cancer	4.12e-05	0.00011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—stomach cancer	4.12e-05	0.00011	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—stomach cancer	4.08e-05	0.000109	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—stomach cancer	4.03e-05	0.000108	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—stomach cancer	4.03e-05	0.000108	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.94e-05	0.000106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—stomach cancer	3.9e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—stomach cancer	3.85e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—stomach cancer	3.81e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.8e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—stomach cancer	3.79e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—stomach cancer	3.71e-05	9.94e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—stomach cancer	3.71e-05	9.93e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C3—stomach cancer	3.7e-05	9.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO1—stomach cancer	3.6e-05	9.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.54e-05	9.5e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—stomach cancer	3.5e-05	9.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—stomach cancer	3.5e-05	9.37e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—stomach cancer	3.38e-05	9.06e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—stomach cancer	3.24e-05	8.67e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—stomach cancer	3.22e-05	8.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD44—stomach cancer	3.2e-05	8.56e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—stomach cancer	3.11e-05	8.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.1e-05	8.31e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—stomach cancer	3.1e-05	8.3e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—stomach cancer	2.98e-05	7.98e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—stomach cancer	2.85e-05	7.63e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.72e-05	7.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—stomach cancer	2.67e-05	7.14e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—stomach cancer	2.63e-05	7.04e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMS—stomach cancer	2.48e-05	6.64e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—stomach cancer	2.45e-05	6.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ERCC2—stomach cancer	2.3e-05	6.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—stomach cancer	2.17e-05	5.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—stomach cancer	2e-05	5.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—stomach cancer	1.99e-05	5.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.91e-05	5.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—stomach cancer	1.76e-05	4.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—stomach cancer	1.58e-05	4.23e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—stomach cancer	1.51e-05	4.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—stomach cancer	1.38e-05	3.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—stomach cancer	8.5e-06	2.28e-05	CbGpPWpGaD
